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RESUMEN
Composición en ácidos grasos de las margarinas de
mayor consumo en España y su importancia nutricional.
Este estudio examina la composición de ácidos grasos de las
margarinas de mayor consumo en España en el año 2000, inclu-
yendo ácidos grasos trans. Todas las margarinas contenían al me-
nos 20% de linoleico, siendo el contenido medio del 38%. Los
ácidos grasos saturados (laúrico y mirístico) no sobrepasaron el
4% del total de ácidos grasos. La mayoría de las margarinas con-
tenían menos del 5% de ácidos grasos trans C18:1, aunque la va-
riabilidad era elevada entre las distintas marcas (coeficiente de
variación:112%), siendo la mediana del 2.5%; los ácidos grasos
trans poliinsaturados C18:2 y C18:3 no representaron más del
1%. Índices nutricionalmente importantes como el cociente áci-
dos grasos saturados/insaturados, índices trombogénico y atero-
génico, fueron menores de 0,5. Los resultados sugieren que las
margarinas españolas muestran un cambio hacia una distribución
de ácidos grasos más saludable, aunque debido a la gran variabi-
lidad en su composición, la información del etiquetado debe me-
jorar  para ev i tar  per turbaciones en la  trad ic ional d ie ta
Mediterránea de España.
PALABRAS-CLAVE: Ácidos grasos – Ácido linoleico – Cro-
matografía de gases – Índice de aterogenicidad – Índice de trom-
bogenicidad – Isómeros trans – Margarinas.
SUMMARY
Fatty acid composition and nutritional relevance of
most widely consumed margarines in Spain.
This study examines the fatty acid composition of margarines
of major consumption in Spain in 2000. All the margarines
contained at least 20% of linoleic acid, the average content of this
fatty acid being 38%. Saturated fatty acids (lauric and miristic
acids) did not exceed 4% of the total fatty acid content. Most of the
margarines analyzed contained less than 5% trans C18:1,
a lthough th is  content  varied greatly  among margarines
(coeff icient of variation: 112%) being median value 2.5%;
polyunsaturated trans C18:2 and trans C18:3 did not represent
m o r e  t h a n  1 % .  N u t r i t i o n a l l y  i m p o r t a n t  r a t i o s  l i k e
saturated/unsaturated fat ty acids, thrombogenic ity  and
atherogenicity indexes were lower than 0.5. The findings suggest
that Spanish margarines have moved to becoming products with a
potentially healthier distribution of fatty acids. Even so, the great
variability shown in fatty acid composition of margarines and poor
labeling, highlight the importance of greater consumer information
to avoid upsetting the traditional Mediterranean diet of Spain.
KEY-WORDS: Atherogenicity index – Fatty acids – Linoleic
acid – Margarines – Trans isomers – Thrombogenicity index.
1. INTRODUCTION
The Mediterranean diet has been described as a
useful model for providing recommended energy and
nutrient levels for different population groups
(Moreiras-Varela, 1989). Spain and most of the
European Mediterranean countries show the lowest
level of cardiovascular disease (CVD) mortality in
Europe (Uemura and Pisa, 1988). Traditionally olive
oil has been the main source of fat in the
Mediterranean diet, although there has been a
gradual increase in margarine and butter
consumption during recent years. Although the direct
consumption of margarine in Spain is still low (2
g/person/day), the intake of foods containing
margarine in their composition (industrial bakery
products, biscuits, etc.) is rising (Serra-Majem et al.,
1993).
There has been controversy surrounding the
safety of margarine. For example, it has been reported
that margarine can safety be consumed in a prudent
diet because it is a source of polyunsaturated fatty
acids (PUFA), lacks cholesterol and contains a level of
saturated fatty acids (SFA) lower than that of animal fat
(Beare-Rogers et al., 1979). However, Willett et al.
(1994) identified margarine as one of the major
sources of trans fatty acids. Several epidemiological
studies have shown an association between dietary
trans fatty acids and CVD but these studies have
been contradictory (Willet et al., 1993; Roberts et al.,
1995; Fritsche et al., 1998). It is known that the
nutritional quality of margarines depends on several
factors: fat sources, manufacturing process, etc. To
achieve the solid consistency necessary for
margarines, manufacturers are permitted to blend the
unmodified liquid oils with a small amount of natural
solid fat or to hydrogenate some edible oils, which
involves the formation of trans fatty acids (Bourr,
1985; Hernández and Boatella, 1986). Margarine
industry has made great strides in making its
products more heart-healthy and is leading the effort
to reduce fat, saturated fat and trans fat (Michels and
Sacks, 1995; Stender et al., 1995; Ovesen et al.,
1996). However, in different countries the processes
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followed to achieve these goals have modified the
nutritional characteristics of the products in different
ways.
For these reasons, the aim of the present study
was to evaluate the fatty acid composition of
margarines widely consumed in Spain in the year
2000 and their propensity to influence the incidence
of coronary heart diseases.
2. MATERIAL AND METHODS
2.1. Sources and sample preparation
Twelve brands of margarines widely consumed in
Spain (O.C.U., 1999) were purchased from local
suppliers in 2000. The products were from the
following margarine-producing factories: Unilever
food Spain S.A., Leioa, Spain; van Dijk Food
Products, Lopik, Holland; Dia S.A., Getafe, Spain;
Grupo Unigro S.A., Valladolid, Spain; Koninklijke
Brinkers, Zeewalde, Holland. Samples of the same
brand were bought and analyzed in May and again in
September 2000, in order to observe differences
between batches. Samples were stored under
refrigeration (4oC) until they were analyzed.
Margarines were homogenized and each sample
was analyzed twice.
2.2. Analytical methods
Analysis of fatty acids
Total lipids were extracted from the margarines
with chloroform/methanol (2:1, v/v) according to the
method of Folch et al. (1957). Fatty acid methyl
esters (FAME) were prepared with methanolic HCl
(1:1) at 85oC for 1 h and dissolved in hexane (Stoffel
et al., 1959). FAME of samples from the year 2000
were analyzed by gas-liquid chromatography (GLC)
using a SP-2560 fused silica capillary column (100 m
x 0.25 mm inner diameter, 20 µm film thickness;
Suppelco, Bellefonte, PA) in a Hewlett-Packard 5890
gas chromatograph (Hewlett-Packard, Avondale,
PA). The oven temperature was programmed for 39
minutes at 175oC and was increased to 230oC at a
rate of 3oC per minute and held for 14 minutes.
Helium was used as the carrier gas at a pressure of
290 kPa. Peaks were identified by comparison with
their retention times with appropriate FAME
standards (Sigma Chemical Company, Urbana, IL).
Finally, the double bond position of isomers were
confirmed by GLC-mass spectrometry analysis of
their 2-alkenyl-4,4-dimethyloxazoline (DMOX)
derivatives (Zhang et al., 1988).
For GLC-mass spectrometry analysis, a VG
Analytical MS System (Model 7070EQ, VG
Analytical, Manchester, England), equipped with an
11/250 data system interfaced to a Varian gas
chromatograph (Model Vista 6000, Varian
Associates, Palo Alto, CA) was operated at an
ionization energy of 70 eV. GLC separation of the
DMOX derivatives was performed on the same
SP-2560 capillary column described for the FAME
analysis. Helium was the carrier gas. The oven
temperature was programmed from 140oC at 1.5oC
per minute to 220oC and held for 15 minutes. For the
final determination of the composition of the C18:1
isomers in margarines, the FAME were fractionated
by silver-nitrate thin-layer chromatography and
further GLC, to avoid the overlap of trans C18:1
(12-trans, 13-trans, 14-trans, 15-trans octadecenoic
acid) with cis C18:1 isomer peaks (Ulberth and
Henninger, 1992). 
Calculated Indices
The saturated/unsaturated fatty acids (SFA/UFA)
ratios were calculated including trans fatty acids in
the UFA group. The atherogenicity (AI) and
thrombogenicity (TI) indices were also calculated
according to the following equations (Ulbricht and
Southgate, 1991)
AI = (aSI + bSII + cSIII)/(dP + eM + fM’), being SI =
C12:0; SII = C14:0; SIII = C16:0; P = sum of n-6 and
n-3 families PUFA; M = cis C18:1; M’ = sum of the
other monounsaturated fatty acids (MUFA); b = 4, a =
c = d = e = f = 1.
TI = mSIV/(nM + oM’ + p(n-6) + q(n-3) + (n-3/n-6),
with SIV= sum of C14:0, C16:0 and C18:0; (n-6) =
sum of the n-6 family PUFA; (n-3) = sum of the n-3
family PUFA; M and M’ = as in the previous equation;
m = 1; q = 3; n = o = p = 0.5.
2.3. Statistical analysis
The contents of the various fatty acids are given
in g per 100 g total fatty acids. The coefficient of
variation (CV) was calculated in order to estimate the
variability of each fatty acid among the different
margarines analyzed. The median was estimated in
order to identify the dispersion of data. To evaluate
differences between batches a Two-way analysis of
variance (ANOVA) considering brand of margarine
and fatty acids was assayed. This analysis was
followed by LSD test when the differences were
significant. 
3. RESULTS
The samples were analyzed in May and again in
September 2000 in order to observe possible
differences between batches. Table I shows the
distribution of identified fatty acids (mean percentage
of total fatty acid weight of each brand of margarine
in both batches, and mean  ± SD and median of total
margarines), as well as their aggregated values,
SFA, MUFA, PUFA and total trans fatty acids. We did
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Com m ercial m argarines***
M 1 M 2 M 3 M 4 M 5 M 6 M 7 M 8 M 9 M 10 M 11 M 12 M ean ± S D Median
0.1 0.2 0.3 tr 0.1 0.1 Tr 0.2 0.1 tr 0.1 0.2 0.1 ± 0.1 0.1
0.3 0.3 0.4 tr 0.2 0.2 0.1 0.2 0.2 tr 0.2 0.3 0.2 ± 0.1 0.2
4.1 3.5 4.1 tr 2.1 2.4 0.1 2.3 3.9 0.1 1.2 4.5 2.4 ± 1.7 2.4
1.6 1.4 1.6 0.1 1.1 1.2 0.1 1.2 1.8 0.2 0.8 1.8 1.1 ± 0.6 1.2
12.3 11.2 12.4 11.4 18.7 21.7 7.1 21.7 16.3 12.9 16.8 16.0 14.9 ± 4.5 14.5
0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 ± 0.0 0.1
8.6 8.4 10.0 5.1 4.6 4.3 15.5 3.2 7.4 7.4 4.6 6.1 7.1 ± 3.4 6.7
0.3 0.3 0.3 0.5 0.3 0.4 0.3 0.4 0.4 0.4 0.4 0.4 0.4 ± 0.1 0.4
0.3 0.5 0.4 0.2 0.5 0.3 0.7 0.2 0.4 0.4 0.3 0.3 0.4 ± 0.1 0.4
tr tr 0.1 tr tr 0.1 Tr tr 0.1 tr tr tr 0.1 ± 0.0 tr
0.2 0.2 0.2 0.1 0.2 0.2 0.2 0.1 0.2 0.2 0.1 0.2 0.2 ± 0.0 0.2
0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 ND 0.1 0.1 0.1 0.1 ± 0.0 0.1
0.1 0.1 1.0 18.6 0.1 0.1 3.1 0.1 6.7 16.4 3.1 6.4 4.6 ± 6.5 2.0
19.7 20.6 19.2 28.3 25.6 25.3 20.9 27.7 24.2 26.7 34.2 25.2 24.8 ± 4.3 25.2
0.9 0.9 1.1 3.9 1.0 1.4 1.5 1.0 2.8 5.2 2.8 2.2 2.1 ± 1.4 1.5
0.1 0.1 0.1 0.2 0.2 0.2 0.1 0.2 0.1 0.1 0.6 0.2 0.2 ± 0.1 0.1
47.7 49.4 45.3 30.0 42.9 36.4 49.5 38.6 30.8 26.1 27.9 33.2 38.2 ± 8.5 37.5
0.1 0.1 0.2 0.1 0.1 0.2 0.2 0.2 0.1 0.1 0.2 0.1 0.1 ± 0.0 0.1
0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 ± 0.0 0.1
ND ND ND tr ND ND Tr ND ND tr. tr tr tr tr
tr tr tr 0.4 ND ND 0.1 tr 0.2 0.6 0.1 0.2 0.1 ± 0.2 tr
0.1 0.1 0.1 tr 0.1 0.2 Tr 0.1 0.1 0.1 0.3 0.1 0.1 ± 0.1 0.1
3.0 2.2 2.6 0.7 1.6 4.5 0.2 1.9 2.9 2.5 5.5 2.2 2.5 ± 1.5 2.3
0.1 0.1 0.1 tr 0.1 0.2 Tr 0.1 0.1 0.1 0.3 0.1 0.1 ± 0.1 0.1
28.1 26.1 29.9 17.5 28.0 31.1 24.2 29.6 30.6 21.8 24.6 30.0 26.8 ± 4.1 28.0
21.0 21.9 21.6 51.1 27.1 27.2 25.7 29.3 33.9 48.6 41.0 34.0 31.9 ± 10.2 28.2
50.9 52.0 48.5 31.4 44.9 41.7 50.1 41.1 35.5 29.6 34.4 36 41.3 ± 7.9 41.4
0.4 0.4 1.5 19.2 0.4 0.6 3.5 0.6 7.2 17.3 3.7 6.9 5.1 ± 6.6 2.5
Fatty acid**
 
 
 
 
 
 
 
 
 
 
 
 
 
Table I
Fatty acid composition (%) and indices of Spanish margarines in 2000*
* Results are expressed in percentage (g per100 g fatty acids), mean ± standard deviation and median of total margarines from both batches.
ND not detectable or tr trace amounts (< 0.1%).
** c, cis ; t, trans; n-x, positional cis isomers; i, other isomers. SFA, saturated fatty acids; MUFA, monounsaturated fatty acids (cis plus trans);
PUFA, polyunsaturated fatty acids (cis plus trans); Trans (total trans fatty acids).
*** M1, Tulipán; M2, Flora; M3, Natacha; M4, Artúa; M5, Sonna; M6, Vegetal Día; M7, Girasol Día; M8, Maíz Día; M9, Ligeresa; M10, Super;
M11, Holland; M12 Yogurina.
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not find significant differences in fatty acid
composition between batches except in two brands, M11
and M12. The fatty acids with the highest differences
between batches in the margarine M11 for the months of
May and September respectively were the following:
C12: 0.6 and 1.9%; C18:1 trans: 6.0 and 0.1%; C18:1
n-9: 24.4 and 44.1%; C18:2 n-6: 35.2 and 20.5%; C18:3
n-3: 3.9 and 7.1%. In margarine M12: C12: 2.7 and
6.3%; C18:1 trans: 10.1 and 2.7%; C18:1 n-9: 27.3 and
23.1%; C18:2 n-6: 32.0 and 34.4%; C18:3 n-3: 1.7 and
2.6%.The margarines analyzed were a rich source of
PUFA, the mean content of these fatty acids being
greater than those of SFA and MUFA (Table I).
However, the CV for these indices in all the brands
analyzed was high: 15, 32 and 19% for SFA, MUFA
and PUFA, respectively. 
The most abundant SFA (approximately 15% of the
total fatty acids) was palmitic acid, while the atherogenic
SFA (lauric and miristic acids) represented only about
4% of the total fatty acid content. The mean linoleic
acid content was greater than 20% in all the
margarines analyzed in 2000 (Table I).
The total trans fatty acid content varied greatly
between the different brands of margarine (Table I)
(CV = 129%) with M4 and M10 showing up to 30
times the levels found in M2 and M5. Because of the
mean value is not very representative of a collective
when the dispersion of the data is very high, we have
calculated the median value for the fatty acids
studied. Only trans fatty acids presented a median
value (2.5%) far away from the mean value (5.1%).
These total trans fatty acids were mainly trans C18:1
type, while trans C18:2 and trans C18:3
polyunsaturated acids did not exceed 1% of the total
fatty acids.
 The derived ratios n-6/n-3, SFA/UFA, AI, and TI
of the margarines analyzed are reported in Table II.
The SFA/UFA, AI and TI values were significantly low
in all margarines, and below 0.5 in all cases.
4. DISCUSSION
Margarines have come a long way from the lard
and tallow used in the late 1800 to the liquid fat
blends and the introduction of hydrogenated fats in
last years of the 20th century. Although some studies
have pointed to a trend in the 90s to use “hard” type
margarines (Annon, 1991; Ovesen et al., 1996;
Ovesen et al., 1998), our study shows that the most
widely consumed margarines in Spain in the present
moment are semisoft and soft margarines,
containing between 20-40% or more than 40%
Table II
Nutritional ratios of margarines of major consumption in Spain*
Brand of
Margarine**
n-6/n-3 SFA/UFA AI TI
M1 15.80 ± 0.41 0.39 ± 0.01 0.32 ±0.00 0.38 ± 0.02
M2 22.29 ± 0.66 0.36 ± 0.01 0.28 ± 0.00 0.33 ± 0.01
M3 17.13 ± 0.90 0.43 ± 0.02 0.33 ± 0.00 0.41 ± 0.02
M4 42.87 ± 0.07 0.21 ± 0.00 0.14 ± 0.00 0.19 ± 0.00
M5 26.25 ± 3.88 0.39 ± 0.01 0.35 ± 0.01 0.37 ± 0.01
M6 7.99 ± 0.56 0.45 ± 0.01 0.42 ± 0.01 0.51 ± 0.00
M7 293.05 ±56.38 0.32 ± 0.00 0.10 ± 0.01 0.07 ± 0.01
M8 19.58 ± 0.94 0.42 ± 0.00 0.41 ± 0.00 0.44 ± 0.00
M9 11.21 ± 1.20 0.45 ± 0.01 0.40 ± 0.02 0.48 ± 0.00
M10 10.42 ± 0.10 0.28 ± 0.00 0.18 ± 0.00 0.37 ± 0.00
M11 5.77 ± 2.83 0.33 ± 0.03 0.28 ± 0.00 0.39 ± 0.06
M12 16.16 ± 3.03 0.43 ± 0.11 0.41 ± 0.12 0.43 ± 0.09
Total 40.71 ±4.92 0.37 ± 0.01 0.30 ± 0.01 0.36 ± 0.00
* Results are expressed as mean ± standard deviation margarines from both batches.
** M1, Tulipán; M2, Flora; M3, Natacha; M4, Artúa; M5, Sonna; M6, Vegetal Día; M7, Girasol Día; M8, Maíz Día; M9, Ligeresa; M10, Super;
M11, Holland; M12 Yogurina.
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linoleic acid, respectively (Ovesen et al., 1996). None
of the margarines analyzed was a hard margarine.
This situation is not surprising, taking into account
that in most of non Mediterranean countries the main
cooking fat is margarine while in Spain, olive oil is the
main source of cooking fat and margarine is usually
used only as a spread.
Compared with the margarines sold in other
European countries too, Spanish margarines are
less solid. For example, the SFA/UFA index is lower
(0.37) than that of Bulgarian (0.78) and Dutch (0.54)
margarines (Tsanev et al., 1998), and the linoleic
acid content is much higher than in Denmark
(Ovesen et al., 1996, 1998). In fact, the high linoleic
acid content of Spanish margarines means that this
food might be considered a vehicle for the distribution
of essential fatty acids (EFA). About half of the
margarines from other Mediterranean countries
(Kafatos et al., 1994) can be classified as hard with a
linoleic acid content of less than 20%. However,
french margarines have a similar linoleic acid content
to Spanish margarines (about 40%) (Bayard and
Wolff, 1995).
In general, the α-linolenic acid content of both
Greek (0.9%) and French (0.5%) margarines
(Kafatos et al., 1994; Bayard and Wolff, 1995) is
lower than that of Spanish margarines (2.5%). In our
study, the n-6/n-3 index was much lower than that
found in other Mediterranean countries (Kafatos et
al., 1994; Bayard and Wolff, 1995). Only in one case
(M7) the n-6/n-3 index exceeded 200.
Although margarine is one of the most convenient
and readily available sources of linoleic acid, the
presence of large amounts of trans fatty acids
detracts from its beneficial qualities. However,
Spanish margarines present much lower levels of
trans fatty acids (Table I) than the margarines of
other industrialized countries: two to four times lower
than in Canada (23.6%) (Ratnayake et al., 1998),
Greece (10%) (Kafatos et al., 1994), New Zeeland
(16.2%) (Lake et al., 1996), and the United States
(22.6%) (Emken, 1995), and similar to the level
observed in French tub margarines (Bayard and
Wolff, 1995). Nevertheless, we, as well as other
authors (Alonso et al., 2000) observed that the trans
fatty acid content in spanish margarine varies
considerably (range = 0.4-19.2%). This finding has
been also made in other countries (Aro et al., 1998).
The mean content of trans-PUFA was very low
(about 0.5%), as was that of the trans C18:2
(9,12-trans, trans octadienoic acid), which is
considered to be one of the most dangerous fatty
acids from a health point of view (Kinsella et al.,
1981). This fatty acid did not exceed 0.02%, and was
not found in seven of the margarines studied (Table
I). The content of trans fatty acids found in our results
(5.8% mean value, median value 2.5%) and similar
studies (8.8% mean value) (Alonso et al., 2000) were
lower than the 16.8% detected in Spain in 1996
(Fernández San Juan, 1996). This results suggest a
move towards lower trans fatty acid content in
spanish margarine. 
Many studies have indicated that high
concentrations of linoleic acid tend to be associated
with low concentrations of trans fatty acids (Beare-
Rogers et al., 1979). This is confirmed by the present
study, in which the margarines with a higher trans
fatty acid content showed lower levels of linoleic acid
(Table I). This is an important finding since several
authors have pointed to the harmless nature of trans
fatty acids in diets containing a sufficient amount of
EFA (Zevenbergen et al., 1988).
The SFA, especially the short-chain fatty acids
such as palmitic acid, lauric acid, and myristic acid
raise blood cholesterol, (Mensink and Katan, 1992)
although they probably do not have the same
atherogenic potential as trans fatty acids (Hu et al.,
1997). In our study, the level of these atherogenic
SFA is below the one observed in other European
countries (Ovesen et al., 1998; Kafatos et al., 1994)
(Tables I and II).
Taken together, all these data suggest that
present day Spanish margarines are healthier
products than their counterparts sold in other
countries. This affects their AI and TI, two parameters
which are widely used in foods to ascertain their
health affecting potential. The mean AI calculated for
the margarines was lower than the index obtained by
our group for pork, rabbit, lamb, turkey, chicken and
beef, and even for the fish analyzed (tuna, hake, sea
bream and sardine) (Pérez-Llamas et al., 1998). This
means that the fat quality of modern Spanish
margarines is extremely acceptable. The TI, on the
other hand, was generally three times higher than for
the above mentioned meats and six times higher
than that of the fish analyzed. 
The wide variations observed in the margarines,
not only as regards to their SFA, MUFA, PUFA, and
trans fatty acids contents (Table I) but also to their TI,
AI, and SFA/UFA indices (Table II), point to their
different propensities for influencing the incidence of
coronary heart disease. The information offered to
the consumer is totally inadequate. Only three of the
margarines show the MUFA, PUFA and SFA data
and only one mentions the trans fatty acid content
(data not shown). None of the labels refers to the
linoleic acid content so that not only is it impossible to
know the EFA content but it is also not possible to
classify the margarines into soft, semisoft or hard.
In summary, our results show that Spanish
margarines have a healthier distribution of fatty acids than
the margarines analyzed in other countries. The
margarines as a whole are potentially less atherogenic
than many widely consumed meat products. However,
the variations seen between the most widely consumed
margarines and the very bad labeling found in this
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study highlight the importance of informing the
consumer in order to avoid upsetting the traditional
Mediterranean diet that characterizes Spain. 
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